Applied BioCode Corporation: Q4 2025 EPS of -NT$1.96
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Applied BioCode Corporation announced its Q4 2025 financial results, reporting an EPS of -NT$1.96, revenue of NT$0.475 billion, and a net loss of NT$0.201 billion, indicating significant R&D investment and potential future growth.
AI Analysis
Frequently Asked Questions
- Q: What was Applied BioCode Corporation's EPS for the 4th quarter of 2025?
- A: EPS was -1.96 yuan.
- Q: What were the operating revenue and net loss after tax for the same quarter?
- A: Operating revenue was 475 million yuan, and net loss after tax was 201 million yuan.
- Q: Which industry does this company belong to?
- A: It belongs to the biotechnology and medical industry.